Clarus Wealth Advisors Sarepta Therapeutics, Inc. Transaction History

Clarus Wealth Advisors

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 10, 2023	BUY	$117.53 - $155.99 $195,804 - $259,879	1,666 New	1,666 $229,000
Q2 2021 Jul 13, 2021	SELL	$69.38 - $86.75 $254,347 - $318,025	-3,666 Closed	0 $0
Q1 2020 Apr 08, 2020	SELL	$82.38 - $131.64 $16,476 - $26,327	-200 Reduced 5.17%	3,666 $343,000
Q3 2019 Oct 11, 2019	BUY	$72.81 - $156.91 $149,260 - $321,665	2,050 Added 112.89%	3,866 $291,000
Q2 2019 Jul 24, 2019	BUY	$112.21 - $151.95 $16,831 - $22,792	150 Added 9.0%	1,816 $276,000
Q4 2018 Jan 08, 2019	BUY	$97.32 - $148.76 $162,135 - $247,834	1,666 New	1,666 $269,000
Q4 2018 Jan 07, 2019	SELL	$97.32 - $148.76 $162,135 - $247,834	-1,666 Closed	0 $0
Q3 2018 Oct 03, 2018	SELL	$115.31 - $161.51 $1,383 - $1,938	-12 Reduced 0.72%	1,666 $269,000
Q2 2018 Jul 05, 2018	BUY	$71.74 - $153.69 $120,379 - $257,891	1,678 New	1,678 $124,000

535

87.4M

1.55M

1.35M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $6.49B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Clarus Wealth Advisors, based on Form 13F filings with the SEC.

Stay updated on Clarus Wealth Advisors with notifications on news.